NIH VideoCast - COVID-19 Scientific Interest Group: Human Antibody Response to SARS-CoV-2 Infection and Vaccination

Skip Navigation

COVID-19 Scientific Interest Group: Human Antibody Response to SARS-CoV-2 Infection and Vaccination

Loading... Loading video...

1,342 Views

Air date:	Thursday, December 2, 2021, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 1,342 (855 Live, 487 On-demand)
Category:	COVID-19
Runtime:	01:01:33
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	COVID-19 Scientific Interest Group Michel C. Nussenzweig is the Zanvil A. Cohn and Ralph M. Steinman Professor at The Rockefeller University, as well as a Howard Hughes Medical Institute Investigator. The Nussenzweig’s laboratory studies the molecular aspects of the immune system’s innate and adaptive responses using a combination of biochemistry, molecular biology, and genetics. For work on adaptive immunity, he focuses on B lymphocytes and antibodies to HIV-1, while his studies of innate immunity focus on dendritic cells. His work is leading to new antibody-based therapies for infections by HIV and the novel SARS-CoV-2 coronavirus, among other viruses. His seminar will focus on the dynamics and evolution of the antibody response to SARS-CoV2 and its variants. For more information go to https://www.niaid.nih.gov/research/covid-19-sig

NLM Title:	Human antibody response to SARS-CoV-2 infection and vaccination / Michel Nussenzweig.
Author:	Nussenzweig, Michel. National Institutes of Health (U.S.). COVID-19 Scientific Interest Group.
Publisher:
Abstract:	(CIT): COVID-19 Scientific Interest Group Michel C. Nussenzweig is the Zanvil A. Cohn and Ralph M. Steinman Professor at The Rockefeller University, as well as a Howard Hughes Medical Institute Investigator. The Nussenzweig laboratory studies the molecular aspects of the immune system's innate and adaptive responses using a combination of biochemistry, molecular biology, and genetics. For work on adaptive immunity, he focuses on B lymphocytes and antibodies to HIV-1, while his studies of innate immunity focus on dendritic cells. His work is leading to new antibody-based therapies for infections by HIV and the novel SARS-CoV-2 coronavirus, among other viruses. His seminar will focus on the dynamics and evolution of the antibody response to SARS-CoV2 and its variants.
Subjects:	Antibody Formation COVID-19 Vaccines--immunology COVID-19--immunology SARS-CoV-2--immunology.
Publication Types:	Lecture Webcast

NLM Classification:	WC 506.6
NLM ID:	9918332580806676
CIT Live ID:	43893
Permanent link:	https://videocast.nih.gov/watch=43893

Related Videos...